Funded Biotechnology Startups in San Mateo
San Mateo's biotechnology cluster spans the full funding lifecycle, from early venture rounds to late-stage capital raises.
San Mateo's biotechnology cluster spans the full funding lifecycle, from early venture rounds to late-stage capital raises. Among the 12 companies in this view, Rakuten Medical's $166M Series D (July 2021) is the largest disclosed round, with Sagimet Biosciences ($113M, January 2024) and Terns Pharmaceuticals ($87M Series C, January 2021) close behind. The most recent activity is concentrated in early 2025: Helicore Biopharma closed a $65M Series A on January 28 and Vivace Therapeutics completed a $35M Series D on March 12.
Several entries carry incomplete round metadata — Selonterra, Sagimet Biosciences, PrognomiQ, and Edifice Health are labeled Series Unknown or Venture - Series Unknown, and Revagenix's Series B amount is undisclosed. Company names across the cohort point to sub-sectors including therapeutics, genomics, diagnostics, and minimally invasive surgical devices, all operating out of San Mateo, California.
Most recent rounds
12 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these San Mateo biotech companies?
Rakuten Medical leads at $166M (Series D, July 2021), followed by Sagimet Biosciences at $113M (January 2024) and Terns Pharmaceuticals at $87M (Series C, January 2021). Helicore Biopharma's $65M Series A from January 2025 is the largest disclosed raise in the most recent 14 months of the dataset.
Which companies raised funding most recently?
The two most recent rounds are Vivace Therapeutics' $35M Series D (March 12, 2025) and Helicore Biopharma's $65M Series A (January 28, 2025). Before those, Selonterra raised $3M in October 2024 and Sagimet Biosciences closed $113M in January 2024.
How is funding distributed across round stages?
The 12 records include two Series D rounds (Vivace Therapeutics, Rakuten Medical), two Series C rounds (Levita Magnetics, Terns Pharmaceuticals), one Series B (Revagenix, amount undisclosed), and one Series A (Helicore Biopharma). Four entries carry Series Unknown or Venture - Series Unknown labels, and two have no round type recorded at all.
Which year saw the most funding rounds in this dataset?
2021 accounts for four of the 12 rounds — Terns Pharmaceuticals (January), Edifice Health (April), Helix (June), and Rakuten Medical (July) — and includes two of the three largest disclosed raises: Rakuten Medical's $166M and Terns Pharmaceuticals' $87M.
Is there a gap in activity between 2022 and 2024?
Based on the records shown, no rounds fall in 2023. The last 2022 entry is Levita Magnetics' $26M Series C (August 2022), and the next recorded activity resumes with Revagenix and Sagimet Biosciences, both in January 2024.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.